Hauser RA - Search Results

1

Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double-blind, placebo-controlled multicenter study.

Goetz CG, Stebbins GT, Chung KA, Nicholas AP, Hauser RA, Merkitch D, Stacy MA. Goetz CG, et al. Among authors: hauser ra. Mov Disord. 2017 Sep;32(9):1335-1336. doi: 10.1002/mds.27092. Epub 2017 Jun 24. Mov Disord. 2017. PMID: 28646494 Clinical Trial. No abstract available.

2

Clozapine withdrawal symptoms in a Parkinson's disease patient.

Zesiewicz TA, Borra S, Hauser RA. Zesiewicz TA, et al. Among authors: hauser ra. Mov Disord. 2002 Nov;17(6):1365-7. doi: 10.1002/mds.10282. Mov Disord. 2002. PMID: 12465085

3

Parkinson's disease home diary: further validation and implications for clinical trials.

Hauser RA, Deckers F, Lehert P. Hauser RA, et al. Mov Disord. 2004 Dec;19(12):1409-13. doi: 10.1002/mds.20248. Mov Disord. 2004. PMID: 15390057

4

Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.

Truong D, Duane DD, Jankovic J, Singer C, Seeberger LC, Comella CL, Lew MF, Rodnitzky RL, Danisi FO, Sutton JP, Charles PD, Hauser RA, Sheean GL. Truong D, et al. Among authors: hauser ra. Mov Disord. 2005 Jul;20(7):783-91. doi: 10.1002/mds.20403. Mov Disord. 2005. PMID: 15736159 Clinical Trial.

5

Chorea in a patient with cerebral palsy: treatment with levetiracetam.

Recio MV, Hauser RA, Louis ED, Radhashakar H, Sullivan KL, Zesiewicz TA. Recio MV, et al. Among authors: hauser ra. Mov Disord. 2005 Jun;20(6):762-4. doi: 10.1002/mds.20414. Mov Disord. 2005. PMID: 15747368

6

Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease.

Zesiewicz TA, Sullivan KL, Maldonado JL, Tatum WO, Hauser RA. Zesiewicz TA, et al. Among authors: hauser ra. Mov Disord. 2005 Sep;20(9):1205-9. doi: 10.1002/mds.20563. Mov Disord. 2005. PMID: 15954135

7

Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease.

Sullivan KL, Staffetti JF, Hauser RA, Dunne PB, Zesiewicz TA. Sullivan KL, et al. Among authors: hauser ra. Mov Disord. 2006 Jan;21(1):115-6. doi: 10.1002/mds.20666. Mov Disord. 2006. PMID: 16142776 Clinical Trial.

8

Use of nutritional supplements in Parkinson's disease patients.

Wolfrath SC, Borenstein AR, Schwartz S, Hauser RA, Sullivan KL, Zesiewicz TA. Wolfrath SC, et al. Among authors: hauser ra. Mov Disord. 2006 Aug;21(8):1098-101. doi: 10.1002/mds.20902. Mov Disord. 2006. PMID: 16639735

9

Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.

Zesiewicz TA, Sullivan KL, Hauser RA, Sanchez-Ramos J. Zesiewicz TA, et al. Among authors: hauser ra. Mov Disord. 2006 Nov;21(11):1998-2001. doi: 10.1002/mds.21061. Mov Disord. 2006. PMID: 16941461

10

Pregabalin (Lyrica) in the treatment of essential tremor.

Zesiewicz TA, Ward CL, Hauser RA, Pease Campbell JA, Sullivan KL. Zesiewicz TA, et al. Among authors: hauser ra. Mov Disord. 2007 Jan;22(1):139-41. doi: 10.1002/mds.21211. Mov Disord. 2007. PMID: 17089400

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

338 results

Search Page

Filters